Summary Safety Review - Benzodiazepines and barbiturates - Assessing the potential risk of negative effects on the development of children’s brains (neurodevelopmental disorders)

Summary Safety Review - Benzodiazepines and barbiturates - Assessing the potential risk of negative effects on the development of children’s brains (neurodevelopmental disorders) is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2024-05-08. On CanQuery you can follow the original downloads. Files are available in English and French.

The Canadian product safety information for lorazepam and midazolam warn that they should not be used during pregnancy. The Canadian product safety information for phenobarbital warns that during pregnancy the drug’s benefit should be weighed against its risk. Also, restrictions for use in children vary from one drug to another.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2024-05-08

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data